Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
EditorialEditorial

Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events

Miguel Ángel González-Gay, Santos Castañeda and Iván Ferraz-Amaro
The Journal of Rheumatology December 2024, jrheum.2024-1204; DOI: https://doi.org/10.3899/jrheum.2024-1204
Miguel Ángel González-Gay
M.Á. González-Gay, MD, PhD, Medicine and Psychiatry Department, University of Cantabria, Santander, and Division of Rheumatology, IISFundación Jiménez Díaz, Madrid.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Miguel Ángel González-Gay
Santos Castañeda
S. Castañeda, MD, PhD, Division of Rheumatology, Hospital Universitario de La Princesa, IIS-Princesa, Madrid.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Santos Castañeda
Iván Ferraz-Amaro
I. Ferraz-Amaro, MD, PhD, Division of Rheumatology, Hospital Universitario de Canarias, and Department of Internal Medicine, Universidad de La Laguna (ULL), Tenerife, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Iván Ferraz-Amaro
  • Article
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Information

jrheum.2024-1204
DOI 
https://doi.org/10.3899/jrheum.2024-1204
PubMed 
39681371

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online December 15, 2024.

Article Versions

  • You are currently viewing a Latest version of this article (December 15, 2024 - 04:00).
  • View the most recent version of this article
Copyright & Usage 
© 2024 The Journal of Rheumatology

Author Information

  1. Miguel Ángel González-Gay,
  2. Santos Castañeda and
  3. Iván Ferraz-Amaro
  1. M.Á. González-Gay, MD, PhD, Medicine and Psychiatry Department, University of Cantabria, Santander, and Division of Rheumatology, IISFundación Jiménez Díaz, Madrid.
  2. S. Castañeda, MD, PhD, Division of Rheumatology, Hospital Universitario de La Princesa, IIS-Princesa, Madrid.
  3. I. Ferraz-Amaro, MD, PhD, Division of Rheumatology, Hospital Universitario de Canarias, and Department of Internal Medicine, Universidad de La Laguna (ULL), Tenerife, Spain.
  1. FUNDING: MÁGG is supported by the Spanish Ministry of Health, Instituto de Salud Carlos III (ISCIII), Spanish Red de Investigación (RICORS; RD24/0007/0031). SC is supported by the Spanish Ministry of Health, Instituto de Salud Carlos III (ISCIII; PI21/01474). IFA is supported by the Spanish Ministry of Health, Instituto de Salud Carlos III (ISCIII), co-funded by European Regional Development Fund (FEDER; PI23/00046).
    COMPETING INTERESTS: The authors declare no conflicts of interest relevant to this article.
  1. Address correspondence to Prof. M.Á. González-Gay, Division of Rheumatology, IIS-Fundación Jiménez Díaz, Avenida de los Reyes Católicos, 2, 28040 Madrid, Spain. Email: miguelaggay{at}hotmail.com.

Article usage

Article usage: December 2024 to October 2025

AbstractFullPdf
Dec 20244700113
Jan 2025237045
Feb 2025108942
Mar 2025467744171
Apr 202510410072
May 2025425962
Jun 2025596327
Jul 2025436938
Aug 2025533815
Sep 2025424334
Oct 2025325819

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology: 52 (11)
The Journal of Rheumatology
Vol. 52, Issue 11
1 Nov 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events
Miguel Ángel González-Gay, Santos Castañeda, Iván Ferraz-Amaro
The Journal of Rheumatology Dec 2024, jrheum.2024-1204; DOI: 10.3899/jrheum.2024-1204

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events
Miguel Ángel González-Gay, Santos Castañeda, Iván Ferraz-Amaro
The Journal of Rheumatology Dec 2024, jrheum.2024-1204; DOI: 10.3899/jrheum.2024-1204
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Improving Mental Health Care for People With Systemic Lupus Erythematosus: Time to Take Action
  • Ample Room for Improvement
  • Confidence in the Use of Immunomodulatory Medications During Pregnancy: How Can Patient and Clinician Experience Be Improved?
Show more Editorials

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire